Patents by Inventor Loren Flynn

Loren Flynn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A BIOMARKER AND USES THEREFOR
    Publication number: 20230348977
    Abstract: The present disclosure relates generally to methods and protocols for the diagnosis, prognosis and stratification of patients with, or at risk of developing, sporadic amyotrophic lateral sclerosis (ALS). In particular, the methods and protocols of the present disclosure are based on determination of the presence and number of cytosine (C) adenine (A) dinucleotide repeats (CA dinucleotides) within the STMN2 gene.
    Type: Application
    Filed: December 4, 2020
    Publication date: November 2, 2023
    Applicants: The University of Western Australia, Murdoch University
    Inventors: Frances THEUNISSEN, Patrick Anthony AKKARI, Loren FLYNN, Ryan ANDERTON
  • TREATMENT FOR SOD1 ASSOCIATED DISEASE
    Publication number: 20220315930
    Abstract: The present invention relates to antisense oligonucleotides that are complimentary to SOD1, leading to decreased expression of SOD1. Reduced expression of SOD1 is beneficial in medical disorders such as Amyotrophic Lateral Sclerosis.
    Type: Application
    Filed: May 1, 2020
    Publication date: October 6, 2022
    Inventors: Stephen Donald Wilton, Susan Fletcher, Loren Flynn, Patrick Anthony Akkari